Clinical Trials Browser

Phase NA × OTHER × EBV-associated Tumors × Clear all

NCT07101536 2025-08-03

The Application of mRNA Immunotherapy Technology in Refractory Malignancies Associated With Epstein-Barr Virus (EBV)

Phase NA Not yet recruiting

EBV-associated Tumors